Myelosuppression due to antineoplastic agents
Shigeoka, Y.; Shimizu, E.
Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
2007
ISSN/ISBN: 0047-1852 PMID: 18074550 Document Number: 609419
Document emailed within 1 workday
Related Documents
Tokutome, A.; Taniguchi, R.; Maeda, K.; Saito, Y.; Ishii, T.; Minami, S.; Wano, Y.; Ota, T.; Saitoh, H.; Takeda, K. 2018: The Usefulness of a Pamphlet for Preventing Exposure to Antineoplastic Agents at Cancer Patients' Homes and an Awareness Survey for Pharmacists about Providing Information to Cancer Patients about Exposure to Antineoplastic Agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(5): 833-839Mitolo-chieppa, D.; Ceci, A. 1974: Neurotoxicity of some antineoplastic agents Bollettino della Societa Italiana di Biologia Sperimentale 50(17): 1333-1359
Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A.M.; Diana, P.; Grimaudo, S.; Mingoia, F.; Barraja, P. 1995: Azolophenanthridines as antineoplastic agents Farmaco 50(6): 365-368
1971: Chemistry of antineoplastic agents Minerva Medica 62(28): 1492
Pettit, G.R.; Srirangam, J.K.; Barkoczy, J.; Williams, M.D.; Boyd, M.R.; Hamel, E.; Pettit, R.K.; Hogan, F.; Bai, R.; Chapuis, J.C.; McAllister, S.C.; Schmidt, J.M. 1998: Antineoplastic agents 365. Dolastatin 10 SAR probes Anti-Cancer Drug Design 13(4): 243-277
Wada, T.; Matsui, H. 2013: Research development of novel antineoplastic agents Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 142(4): 149
Berti, T. 1970: Specific histotropism of antineoplastic agents La Clinica Terapeutica 55(4): 293-303
Kato, T.; Nemoto, R. 1982: Clinical application of microencapsulated antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 40(2): 478-488
Takeuchi, A. 1980: Bronchial artery infusion of antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 38(7): 2683-2690
Schmoll, H.J.; Hiddemann, W.; Rustum, Y.; Köhne-Wömpner, C.H. 1992: The emerging role for biomodulation of antineoplastic agents Seminars in Oncology 19(2 Suppl 3: 1-3
Sakurai, Y. 1975: Deveolpment of new antineoplastic agents and their clinical characteristics Nihon Rinsho. Japanese Journal of Clinical Medicine 33(5): 1892-1896
Matsumura, Y. 1982: Intravesical instillation of adriamycin and other antineoplastic agents Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(3): 372-376
Babaian, I.S.; Khudaverdian, N.V.; Karapetian, L.G.; Kazarian, R.S.; Sogomonian, L.R. 1997: Comparative study of three antineoplastic alkylating agents on DNA Biofizika 42(2): 542-543
Orfi, L.; Wáczek, F.; Szabó, M.; Kövesdi, I.; Mészáros, G.; Idei, M.; Horváth, A.; Hollósy, F.; Mák, M.; Szegedi, Z.; Szende, B.; Kéri, G.; Noszál, B. 1999: Preparation and characterization of potential antineoplastic agents Acta Pharmaceutica Hungarica 69(3): 115-122
Le Guern, M. 1987: DNA-topoisomerase II: Cellular targets of antineoplastic agents Pathologie-Biologie 35(4): 343-345
2007: Results of screening of antineoplastic agents: the twelfth report Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34 Suppl. 1: 112-145
Cohen, S.C.; Gabelnick, H.L.; Johnson, R.K.; Goldin, A. 1975: Effects of antineoplastic agents on wound healing in mice Surgery 78(2): 238-244
Ashwin, J. 1983: Agencies cooperate in ensuring safe use of antineoplastic agents Canadian Medical Association Journal 128(8): 907-908
Adenis, L.; Cappelaere, P.; Demaille, A. 1974: Recent antineoplastic agents in the treatment of solid tumors Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 19 Spec No: 343-349
Presnova, Z.F.; Chernov, V.A. 1971: Effect of adrenomimetic agents on the antineoplastic activity of thiophosphamide Farmakologiia i Toksikologiia 34(4): 456-460